Epidemiology, Frequency, Distribution, Mechanisms, and Histopathology
The number of newly diagnosed patients with malignant disease continues to rise annually. Fortunately, the prognostic outlook for these individuals is no longer universally grim. Significant progress has been made in understanding cancer biology and natural defense mechanisms and in the development of new and aggressive treatment modalities. There is evidence of an overall increase in survival time and, in a growing number of cases, the opportunity for curative therapy.
KeywordsToxicity Lymphoma Leukemia Anemia Oncol
Unable to display preview. Download preview PDF.
- 2.Sonis AT, Sonis ST: Oral complications of cancer chemotherapy in pediatric patients. J Pedodontics 3:122–128, 1979.Google Scholar
- 10.Sonis AL, Sonis ST: Gingival crevice lymphoblasts in children with acute lymphoblastic leukemia. J Periodon- tol 52:276–279, 1981.Google Scholar
- 13.Dreizen S, Bodey GP, Rodriguez V: Oral complications of cancer chemotherapy. Postgrad Med 58:95–82, 1975.Google Scholar
- 14.Volger W, Huguley C, and Kerr W: Toxicity and antitumor effect of divided doses of methotrexate. Arch Intern Med. 115:285–293, 1965.Google Scholar
- 15.Archibald D: Personal Communication.Google Scholar
- 17.Brown LR, Dreizen S, Bodey GP: Effect of immunosuppression on the human oral flora. In Comparative Immunology of the Oral Cavity, Mergenhagen, SE Scherp HW (eds), DHEW Publication (NIH) 73–438,1973, pp. 204–220.Google Scholar